As was observed in CRC, hypermethylation of EGFL7 leads to a downregulation of miR-126-3p, which targets ADAM9 and subsequently reduces downstream signaling of the EGFR-AKT pathway [123]. Here, EGFL7 is linked to colorectal carcinoma.